These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19234797)

  • 1. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin.
    Neznamov GG; Teleshova ES
    Neurosci Behav Physiol; 2009 Mar; 39(3):311-21. PubMed ID: 19234797
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
    Neznamov GG; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):33-42. PubMed ID: 18697252
    [No Abstract]   [Full Text] [Related]  

  • 3. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
    Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
    [No Abstract]   [Full Text] [Related]  

  • 4. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
    Zavadenko NN; Guzilova LS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):43-8. PubMed ID: 18427539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents.
    Zavadenko NN; Guzilova LS
    Neurosci Behav Physiol; 2009 May; 39(4):323-8. PubMed ID: 19340573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 8. [Noopept in the treatment of mild cognitive impairment in patients with stroke].
    Amelin AV; Iliukhina AIu; Shmonin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):44-6. PubMed ID: 22500312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selection of neuromethabolic drug in severe brain injury].
    Zaĭtsev OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):66-9. PubMed ID: 21246892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of the formation and possibilities of treatment of posttraumatic cognitive disturbances].
    Litvinenko IV; Emelin AIu; Vorob'ev SV; Lobzin VIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):60-6. PubMed ID: 21311490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of fast-acting adaptogens and symptomatic means during evacuation of trauma victims by air transportation].
    Grechko AT; Glaznikov LA
    Aviakosm Ekolog Med; 1997; 31(2):47-9. PubMed ID: 9190256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].
    Bochkarev VK; Teleshova ES; Siuniakov SA; Davydova DV; Neznamov GG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):47-54. PubMed ID: 19008801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment and long-term follow-up of post-anoxic myoclonus].
    Janszky J; Holló A; Halász P
    Orv Hetil; 2001 Sep; 142(38):2091-3. PubMed ID: 11697066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of cognitive and emotional-volitional disorders in children and adolescents with refractory epilepsy during the treatment with levetiracetam].
    Popov IuV; Iakovleva IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):48-52. PubMed ID: 23739514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the long-term behavioral effects of noopept and piracetam in adult male rats and female rats in postnatal period].
    Voronina TA; Guzevatykh LS; Trofimov SS
    Eksp Klin Farmakol; 2005; 68(2):3-7. PubMed ID: 15934357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of rutin on cognitive impairment caused by phenytoin.
    Dubey S; Ganeshpurkar A; Bansal D; Dubey N
    Indian J Pharmacol; 2015; 47(6):627-31. PubMed ID: 26729954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [4th International Symposium. "Cerebrolysin: pharmacological effects and role in clinical practice"].
    Gomazkov OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):69-70. PubMed ID: 12378888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.